clinical trial · NCT04856904
Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation
Galderma R&D·phase4·completed·n = 121
Acne VulgarisTrifarotene CreamTrifarotene Vehicle Cream
brief summary
The purpose of this study is to evaluate the safety and efficacy of trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle on the risk of formation of atrophic acne scars after 24 weeks of treatment in facial acne participants assessed by atrophic acne scars count.
started
May 28, 2021
primary completion
Feb 8, 2023
completion
Jun 30, 2023
last updated
Jun 11, 2024
official title
Evaluation of the Risk of Atrophic Acne Scar Formation During Treatment of Acne Vulgaris Subjects With Trifarotene 50 μg/g Cream Versus Vehicle Cream Over 24 Weeks
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol